本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aprea Therapeutics, Inc.

1.59
-0.0150-0.94%
成交量:5.63萬
成交額:8.90萬
市值:923.30萬
市盈率:-0.69
高:1.62
開:1.62
低:1.54
收:1.60
52周最高:5.01
52周最低:1.41
股本:582.53萬
流通股本:431.55萬
量比:1.35
換手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-2.3101
每股收益(LYR):-2.3519
淨資產收益率:-67.54%
總資產收益率:-39.12%
市淨率:0.69
市盈率(LYR):-0.67

資料載入中...

2020/05/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/15

重要事件披露

8-K - Current report
2020/04/03

重要事件披露

Current report, item 8.01
2020/03/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/26

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/12/16

重要事件披露

Current report, items 4.01 and 9.01
2019/11/18

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/14

重要事件披露

Current report, items 2.02 and 9.01
2019/11/14

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

超過5%披露

General statement of acquisition of beneficial ownership
2019/10/17

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

超過5%披露

General statement of acquisition of beneficial ownership
2019/10/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/09

超過5%披露

Statement of acquisition of beneficial ownership by individuals